Takuya Iwamoto

Mie University Hospital

Papers

1

Total Citations

49

H-Index

1

About

Takuya Iwamoto is a leading researcher in pharmaceutical robotics and the safe handling of hazardous drugs, with a primary focus on the automation of anticancer drug compounding. His most cited work, a 2017 performance evaluation of the APOTECAchemo compounding robot in a Japanese hospital, has garnered 49 citations and stands as a landmark study in the field. In this research, Iwamoto rigorously assessed the accuracy, precision, and feasibility of robotic preparation for injectable anticancer drugs like fluorouracil and cyclophosphamide, directly addressing critical safety and quality concerns in clinical pharmacy practice. By demonstrating that robotic systems can achieve high precision while minimizing human exposure to cytotoxic agents, his work has provided pivotal evidence for the adoption of automation in hospital pharmacies. This contribution not only advances occupational safety for healthcare workers but also sets a benchmark for quality control in chemotherapy preparation. Through his pioneering evaluation, Iwamoto has established himself as a key figure bridging pharmacy practice and engineering, influencing both Japanese healthcare standards and global discussions on the future of sterile compounding.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital
49 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Mie University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago